Modern problems of treatment of Helicobacter-associated diseases in children: opportunities of adjuvant therapy

Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 2

Abstract

Background. The relevance of research is related to a significant spread of the pathology of the upper digestive tract in children, which in most cases is caused by the pathogenic effect of Helicobacter pylori (Hp). Modern eradication strategies require adjuvant therapy. The aim of the study was to evaluate the clinical effectiveness of the Lactiale symbiotic as an adjuvant therapy for eradication schemes in children of different ages with the pathology of the upper digestive canal. Materials and methods. Seventy children with Hp-associated pathology of the upper digestive tract aged 5 to 18 years were under observation. Patients were divided into 2 groups depending on the use of the symbiotic. The diagnosis was verified using fibrogastroscopy, endoscopic pH-metry, determination of Hp-infection, morphological examination. The results were statistically processed. Results. The results of using Lactiale symbiotic in patients of group 1 as an adjuvant therapy for standard pediatric Hp eradication schemes suggest the expediency and high effectiveness of such treatment. The dyna- mics of complaints, absence of side effects and good tolerabi-lity of drugs against the background of reception of a symbiotic were positive. The increase in eradication efficiency by 10 % compared with standard schemes corresponds to the results of other studies. The positive influence of the symbiotic on the processes of qualitative healing of ulcers and a significant increase in anti-inflammatory effect in patients of the main subgroup with peptic ulcer of the duodenum was determined. The low result of eradication, obtained in patients with functional disorders, can be considered predictable. This is evidenced by the latest conciliatory conclusions of experts: the effectiveness of eradication in patients with functional dyspepsia does not exceed 15–30 %. Conclusions. The use of the Lactiale symbio-tic as an adjuvant therapy for eradication schemes in children of different ages with Hp-associated pathology of the upper digestive tract is advisable, significantly increases the effectiveness of eradication, improves the tolerability of drugs, adhe-rence of patients to the treatment.

Authors and Affiliations

O. Yu. Belousova, N. V. Pavlenko, K. V. Voloshin, O. B. Hanzii, O. L. Slobodianiuk

Keywords

Related Articles

The Approaches to Deworming of Children

The urgency of the problem of the treatment of parasitosis is not in doubt. The World Health Organization has included the control of soil-transmitted helminthiasis into the Global strategy of development. Our study of w...

Role of the Gut Microbiota in the Development of Lipid and Carbohydrate Metabolism in the Liver Steatosis in Children

Background. Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance, dyslipi­demia and obesity. Recent evidence supports a role of the gut microbiota in the pathogenesis of NAFLD. Changes in the mi...

To the Question on Urine Diversion in Congenital Hydronephrosis in Children

Introduction. Hydronephrosis in children is an obstruction of pyeloureteral segment, which is usually diagnosed antenatal by ultrasound screening in 1.5 % of pregnancies. Pathophysiology is still unknown. The most common...

Ways of Improving the Training of Interns Pediatricians and General Practitioners — Family Physicians in «Pediatrics» Discipline

Graduates of medical schools having sufficient theoretical and practical skills often have difficulty in communicating with patients — children and their parents, as well as with colleagues. Objective: improving the effi...

Dysmetabolic nephropathy as a risk factor of pylonephritis in children

Background. Dysmetabolic nephropathies contribute to the development of urinary stone disease in children, the emergence of an infection of the urinary system, secondary pyelonephritis and formation of tubulo-interstitia...

Download PDF file
  • EP ID EP184105
  • DOI 10.22141/2224-0551.12.2.1.2017.100987
  • Views 79
  • Downloads 0

How To Cite

O. Yu. Belousova, N. V. Pavlenko, K. V. Voloshin, O. B. Hanzii, O. L. Slobodianiuk (2017). Modern problems of treatment of Helicobacter-associated diseases in children: opportunities of adjuvant therapy. Здоров`я дитини, 12(2), 239-248. https://europub.co.uk/articles/-A-184105